BK channels in microglia are required for morphine-induced hyperalgesia

Nature Communications

Volumn 7, Issue , 2016, Pages

  Hayashi, Yoshinori ^a   Morinaga, Saori ^a   Zhang, Jing ^a   Satoh, Yasushi ^b   Meredith, Andrea L ^c   Nakata, Takahiro ^d   Wu, Zhou ^a   Kohsaka, Shinichi ^e   Inoue, Kazuhide ^a,f   Nakanishi, Hiroshi ^a,f  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d HAMAMATSU UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^f JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CALCIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MORPHINE; MU OPIATE RECEPTOR; POTASSIUM CHANNEL; IBERIOTOXIN; KCNMA1 PROTEIN, MOUSE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; NARCOTIC ANALGESIC AGENT; PEPTIDE; PURINERGIC P2X4 RECEPTOR;

CELLS AND CELL COMPONENTS; DRUG; GENE; NEUROLOGY; THEORETICAL STUDY; TOLERANCE;

ANIMAL CELL; ANTINOCICEPTION; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; HYPERALGESIA; MICROGLIA; MORPHINE INDUCED HYPERALGESIA; MOUSE; NEUROTRANSMISSION; NONHUMAN; SYNAPTIC TRANSMISSION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; DRUG TOLERANCE; GENE SILENCING; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; NERVE CELL; NOCICEPTION; PAIN; PAIN MEASUREMENT; PATHOLOGY; PHYSIOLOGY; PRIMARY CELL CULTURE; RAT; SPINAL CORD; TRANSGENIC MOUSE; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; ARACHIDONIC ACID; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DRUG TOLERANCE; GENE SILENCING; HUMANS; HYPERALGESIA; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MORPHINE; MUTATION; NEURONS; NOCICEPTION; PAIN; PAIN MEASUREMENT; PEPTIDES; PRIMARY CELL CULTURE; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; RECEPTORS, PURINERGIC P2X4; SPINAL CORD;

EID: 84973390633     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11697     Document Type: Article

References (68)

1. Inturrisi, C. E. Clinical pharmacology of opioids for pain. Clin. J. Pain 18, S3-S13 (2002).
2. Trujillo, K. A. & Akil, H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87 (1991).
3. Drdla, R., Gassner, M., Gingl, E. & Sandkuhler, J. Induction of synaptic long-term potentiation after opioid withdrawal. Science 325, 207-210 (2009).
4. Santamarta, M. T., Ulibarri, I. & Pineda, J. Inhibition of neuronal nitric oxide synthase attenuates the development of morphine tolerance in rats. Synapse 57, 38-46 (2005).
5. Mao, J., Price, D. D. & Mayer, D. J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14, 2301-2312 (1994).
6. Mayer, D. J., Mao, J., Holt, J. & Price, D. D. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Natl Acad. Sci. USA 96, 7731-7736 (1999).
7. Luginbuhl, M. et al. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth. Analg. 96, 726-732 (2003).
8. Joly, V. et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103, 147-155 (2005).
9. Weinbroum, A. A. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth. Analg. 96, 789-795 (2003).
10. Trujillo, K. A. & Akil, H. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res. 633, 178-188 (1994).
11. Celerier, E. et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92, 465-472 (2000).
12. Laulin, J. P. et al. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth. Analg. 94, 1263-1269 (2002).
13. Bell, R. F. Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain 83, 101-103 (1999).
14. Lilius, T. O. et al. Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat. Br. J. Pharmacol. 172, 2799-2813 (2015).
15. Ryder, S., Way, W. L. & Trevor, A. J. Comparative pharmacology of the optical isomers of ketamine in mice. Eur. J. Pharmacol. 49, 15-23 (1978).
16. Chen, X., Shu, S. & Bayliss, D. A. HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine. J. Neurosci. 29, 600-609 (2009).
17. Hevers, W., Hadley, S. H., Luddens, H. & Amin, J. Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits. J. Neurosci. 28, 5383-5393 (2008).
18. Hayashi, Y. et al. Microglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain. J. Neurosci. 31, 17370-17382 (2011).
19. Horvath, R. J., Romero-Sandoval, E. A. & De Leo, J. A. Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and mu opioid receptor protein expression while enhancing perivascular microglial ED2. Pain 150, 401-413 (2010).
20. Ferrini, F. et al. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl(-) homeostasis. Nat. Neurosci. 16, 183-192 (2013).
21. Muscoli, C. et al. Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids. J. Neurosci. 30, 15400-15408 (2010).
22. Cui, Y. et al. A novel role of minocycline: attenuating morphine anti-nociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain. Behav. Immun. 22, 114-123 (2008).
23. Fukagawa, H., Koyama, T., Kakuyama, M. & Fukuda, K. Microglial activation involved in morphine tolerance is not mediated by toll-like receptor 4. J. Anesth. 27, 93-97 (2013).
24. Matsushita, Y., Omotuyi, I. O., Mukae, T. & Ueda, H. Microglia activation precedes the anti-opioid BDNF and NMDA receptor mechanisms underlying morphine analgesic tolerance. Curr. Pharm. Des. 19, 7355-7361 (2013).
25. Sheehan, J. J., Benedetti, B. L. & Barth, A. L. Anticonvulsant effects of the BK-channel antagonist paxilline. Epilepsia 50, 711-720 (2009).
26. Liu, J. et al. CRL4A(CRBN) E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis. Nat. Commun. 5, 3924 (2014).
27. Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778-783 (2003).
28. Coull, J. A. et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017-1021 (2005).
29. Masuda, T. et al. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 1, 334-340 (2012).
30. Masuda, T. et al. Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic pain. Nat. Commun. 5, 3771 (2014).
31. Meredith, A. L., Thorneloe, K. S., Werner, M. E., Nelson, M. T. & Aldrich, R. W. Overactive bladder and incontinence in the absence of the BK large conductance Ca2+-activated K+ channel. J. Biol. Chem. 279, 36746-36752 (2004).
32. Fukuda, K., Kato, S., Morikawa, H., Shoda, T. & Mori, K. Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem. 67, 1309-1316 (1996).
33. Ikeda, H., Heinke, B., Ruscheweyh, R. & Sandkuhler, J. Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299, 1237-1240 (2003).
34. Zeng, J., Thomson, L. M., Aicher, S. A. & Terman, G. W. Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats. J. Neurosci. 26, 12033-12042 (2006).
35. Qureshi, O. S., Paramasivam, A., Yu, J. C. & Murrell-Lagnado, R. D. Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J. Cell Sci. 120, 3838-3849 (2007).
36. Funabashi, K. et al. Accelerated Ca2+ entry by membrane hyperpolarization due to Ca2+-activated K+ channel activation in response to histamine in chondrocytes. Am. J. Physiol. Cell Physiol. 298, C786-C797 (2010).
37. Trang, T., Beggs, S., Wan, X. & Salter, M. W. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci. 29, 3518-3528 (2009).
38. Sun, X., Zhou, D., Zhang, P., Moczydlowski, E. G. & Haddad, G. G. Beta-subunit-dependent modulation of hSlo BK current by arachidonic acid. J. Neurophysiol. 97, 62-69 (2007).
39. Kim, K. K., Adelstein, R. S. & Kawamoto, S. Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors. J. Biol. Chem. 284, 31052-31061 (2009).
40. Zeng, X., Xia, X. M. & Lingle, C. J. Species-specific Differences among KCNMB3 BK beta3 auxiliary subunits: some beta3 N-terminal variants may be primate-specific subunits. J. Gen. Physiol. 132, 115-129 (2008).
41. Salkoff, L., Butler, A., Ferreira, G., Santi, C. & Wei, A. High-conductance potassium channels of the SLO family. Nat. Rev. Neurosci. 7, 921-931 (2006).
42. Kettenmann, H., Hanisch, U. K., Noda, M. & Verkhratsky, A. Physiology of microglia. Physiol. Rev. 91, 461-553 (2011).
43. Chen, S. R., Cai, Y. Q. & Pan, H. L. Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain. J. Neurochem. 110, 352-362 (2009).
44. Mattioli, T. A. et al. Toll-like receptor 4 mutant and null mice retain morphineinduced tolerance, hyperalgesia, and physical dependence. PLoS ONE 9, e97361 (2014).
45. Li, J., Al-Khalili, O., Ramosevac, S., Eaton, D. C. & Denson, D. D. Protein-protein interaction between cPLA2 and splice variants of alpha-subunit of BK channels. Am. J. Physiol. Cell Physiol. 298, C251-C262 (2010).
46. Trang, T., Quirion, R. & Jhamandas, K. The spinal basis of opioid tolerance and physical dependence: Involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites. Peptides 26, 1346-1355 (2005).
47. Martin, H. A., Basbaum, A. I., Goetzl, E. J. & Levine, J. D. Leukotriene B4 decreases the mechanical and thermal thresholds of C-fiber nociceptors in the hairy skin of the rat. J. Neurophysiol. 60, 438-445 (1988).
48. Trang, T., McNaull, B., Quirion, R. & Jhamandas, K. Involvement of spinal lipoxygenase metabolites in hyperalgesia and opioid tolerance. Eur. J. Pharmacol. 491, 21-30 (2004).
49. Polakiewicz, R. D., Schieferl, S. M., Dorner, L. F., Kansra, V. & Comb, M. J. A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J. Biol. Chem. 273, 12402-12406 (1998).
50. Lin, L. L. et al. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269-278 (1993).
51. Harizi, H., Juzan, M., Moreau, J. F. & Gualde, N. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism. J. Immunol. 170, 139-146 (2003).
52. Contreras, G. F., Neely, A., Alvarez, O., Gonzalez, C. & Latorre, R. Modulation of BK channel voltage gating by different auxiliary beta subunits. Proc. Natl Acad. Sci. USA 109, 18991-18996 (2012).
53. Brenner, R. et al. BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat. Neurosci. 8, 1752-1759 (2005).
54. Piwonska, M., Wilczek, E., Szewczyk, A. & Wilczynski, G. M. Differential distribution of Ca2+-activated potassium channel beta4 subunit in rat brain: immunolocalization in neuronal mitochondria. Neuroscience 153, 446-460 (2008).
55. Brenner, R., Jegla, T. J., Wickenden, A., Liu, Y. & Aldrich, R. W. Cloning and functional characterization of novel large conductance calcium-activated potassium channel beta subunits, hKCNMB3 and hKCNMB4. J. Biol. Chem. 275, 6453-6461 (2000).
56. Uebele, V. N. et al. Cloning and functional expression of two families of beta-subunits of the large conductance calcium-activated K+ channel. J. Biol. Chem. 275, 23211-23218 (2000).
57. Behrens, R. et al. hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel beta subunit family. FEBS Lett. 474, 99-106 (2000).
58. Kawasaki, Y., Zhang, L., Cheng, J. K. & Ji, R. R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 28, 5189-5194 (2008).
59. Hayashi, Y., Ishibashi, H., Hashimoto, K. & Nakanishi, H. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia 53, 660-668 (2006).
60. Denson, D. D. & Eaton, D. C. Ketamine inhibition of large conductance Ca(2+)-activated K+ channels is modulated by intracellular Ca2+. Am. J. Physiol. 267, C1452-C1458 (1994).
61. Bohn, L. M., Gainetdinov, R. R., Lin, F. T., Lefkowitz, R. J. & Caron, M. G. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720-723 (2000).
62. Harvey, R. J. et al. GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 304, 884-887 (2004).
63. Hirasawa, T. et al. Visualization of microglia in living tissues using Iba1-EGFP transgenic mice. J. Neurosci. Res. 81, 357-362 (2005).
64. Takenouchi, T., Ogihara, K., Sato, M. & Kitani, H. Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line. Biochim. Biophys. Acta 1726, 177-186 (2005).
65. Nakamichi, K. et al. Suppressive effect of simvastatin on interferon-betainduced expression of CC chemokine ligand 5 in microglia. Neurosci. Lett. 407, 205-210 (2006).
66. Hayashi, Y. et al. Diurnal spatial rearrangement of microglial processes through the rhythmic expression of P2Y12 receptors. J. Neurol. Disord. 1, 120 (2013).
67. Zhang, R. et al. Inhibition of NMDA-induced outward currents by interleukin- 1beta in hippocampal neurons. Biochem. Biophys. Res. Commun. 372, 816-820 (2008).
68. Hayashi, Y. et al. The intrinsic microglial molecular clock controls synaptic strength via the circadian expression of cathepsin S. Sci. Rep. 3, 2744 (2013).